The effects of exogenously administered ethanolamine (Etn) on the N-nitrosodiethylamine (NDA)-induced formation of hepatic lesions in rats were investigated. Sprague-Dawley rats were intraperitoneally administered NDA (100 mg/kg body weight) at 7-day intervals, and the animals were allowed free access to water containing Etn (15 or 50 mg/L) for 35 days. NDA-induced hepatic lesions were assessed according to the number of nodules detectable on the liver surface, areas of clear cell foci observed on histopathological thin sections, hydroxyproline levels in liver homogenates, and blood biochemical marker levels. Compared with those from control rats that were not administered Etn, livers from Etn-exposed rats had significantly fewer surface nodules and smaller areas of clear cell foci, indicating that Etn prevented or delayed the formation of preneoplastic cell alterations. Hydroxyproline levels in livers were significantly lower in Etn-treated rats, indicating that the chemical prevented the formation of fibrotic alterations. The protective effects of Etn on NDA-induced hepatic lesions were demonstrated by changes in blood biochemical marker levels. These results suggest that Etn can protect against cellular alterations induced by a carcinogenic chemical, possibly by enhancing hepatic phospholipid synthesis. 
Introduction
Ethanolamine (Etn) is a nutrient synthesized from serine in vivo or supplied from food, and it is metabolized as a substrate for synthesizing phosphatidylethanolamine (PE), one of the major phospholipids constituting the mammalian cell membrane. In most cells, Etn is phosphorylated, after which it combines with 1,2-diacylglycerol to form PE. Synthesized PE is integrated into membranes [1] [2] [3] [4] . In hepatocytes, a second pathway for synthesizing phosphatidylcholine (PC) in addition to the major pathway involving choline combining with 1,2-diacylglycerol exists; specifically, three methyl molecules provided from S-adenosylmethionine are added to the Etn moiety in PE to generate PC [5] . Approximately 30% of PC in hepatocytes is produced by the secondary pathway [6] .
It was reported that Etn accelerates the proliferation of cultured cells, in which the agent promotes PE synthesis concomitantly [7] . It was also reported that Etn enhances the proliferation of hepatocytes in primary culture by potentiating the action of growth factors [8] [9] . Although the mechanism of potentiation is unknown, one evident point is that PE and PC synthesis is apparently associated with cell growth activation by Etn in hepatocytes [10] .
Stimulation of cell proliferation by Etn is observed in the regenerating liver after partial hepatectomy, in which PE and PC synthesis is enhanced [8] [11] . In the regenerating liver, cell proliferation is stimulated by growth factors such as HGF and EGF [12] [13] . It is speculated that Etn potentiates the activity of growth factors in regenerating areas. During this activity, reorganization of the newly regenerating liver tissue occurs. In Etn-exposed livers, hepatocyte proliferation is enhanced in regenerating areas of the liver without causing structure distortion.
If the liver is injured by chemical substances, then liver regeneration occurs [14] . In damaged areas in injured livers, both cell proliferation and tissue reorganization proceed. If hepatotoxic chemicals are repetitively administered, injuries are continually induced. In injured areas, hepatocyte proliferation will start each time chemicals are administered before structure reconstruction is completed. Growth factors such as HGF exert a protective effect against the progression of liver injury [15] [16] . This effect might be due to the activation of cell proliferation and metabolism of hepatocytes by growth factors. Growth factors can activate many different metabolic pathways including detoxifying systems such as the antioxidant system, which metabolizes reactive oxygen species to inactive molecules [17] .
As Etn activates growth factors, it is speculated that the agent can exert an enhanced protective effect on chemically induced liver injury. This protection might reduce the frequencies of the cycle of damage and restoration. In this paper, the effect of Etn on liver injury induced by repetitive administration of N-nitrosodiethylamine (NDA), which is known to induce liver injury with fibrosis, was assessed. 
Blood Collection and Liver Resection
Rats were fasted 24 h before dissection, and blood was collected via the descending aorta. After coagulation, serum was separated by centrifugation and used for biochemical analyses. The liver of each animal was resected after blood collection. The right lobe of the resected liver was dissected into two parts. One part was fixed in 10% formalin, and the other was frozen at −80˚C for further analyses. All sample collections were performed after animals were anesthetized using Nembutal.
Biochemical Analysis
The collected sera were subjected to biochemical analyses to measure alanine
bilirubin (mg/dL) levels. These biochemical markers were assayed using appropriate colorimetric assay kits (Wako, Japan).
Assessments of Hepatic Lesions and Alterations
The surfaces of both the dorsal and ventral sides of resected livers were photographed. White and round nodules detected on the surfaces of both sides were counted. The right lobe of each resected liver was processed to prepare thin paraffin sections, which were stained using Masson's trichrome. Microscopic fields of stained preparations from all resected livers were randomly selected and digitally photographed. Three photographed fields were analyzed using ImageJ 
Hydroxyproline Quantification
Fifty milligrams of the right lobe were hydrolyzed in saturated HCl for amino acid analysis. Amino acids were quantified using the PTH-amino acid method.
Statistical Analysis
All results were analyzed using Dunnett's test.
Results
On the liver surface, white and round nodules were found as alterations induced by NDA administration (Figure 1(a) ). These nodules were predominantly found in the livers of rats administered NDA alone, whereas nodule counts were significantly lower in Etn-treated rats (Figure 1(b) ). These macroscopically ob- To quantitatively assess the severity of fibrosis, levels of hydroxyproline, a collagen-specific amino acid, in hydrolyzed liver tissue were measured. Hydroxyproline levels were significantly lower in the livers of Etn-treated rats than in control animals administered only NDA (Figure 3) . The results indicate that Etn ameliorated NDA-induced fibrosis in a quantitative manner.
Lesions formed in livers were assessed according to blood biochemical marker levels. Levels of AST, which can denote liver injury were lower in rats administered Etn than the control rats that only received NDA (Figure 4 ), whereas those of ALT were decreased by Etn administration without significance. Meanwhile, those of γ-GTP, ALP, and bilirubin, which are indicative of biliary dysfunction, were also depressed in Etn-treated rats ( Figure 5 ). Compared to AST levels, which were significantly different depending on the Etn concentration, those of ALT were not affected by the Etn concentration. The low AST/ALT ratio indicates that the biliary lesions were more dominant than hepatocyte destruction [18] . This finding is correlated with the elevated levels of the other enzymes. 
Discussion
This study described the effects of Etn on hepatic injuries induced by NDA in rats. The major findings were that Etn prevented the formation of preneoplastic lesions, and clear cell foci, and it also prevented the development of fibrosis at the periphery of the foci.
Etn enhances hepatocyte proliferation following hepatectomy [8] . Because Etn enhances PE synthesis in hepatocytes [11] , it is speculated that Etn enhances The carcinogenic potency of NDA is attributed to its capabilities to induce DNA damage and oxidative stress. NDA can alkylate DNA via cytochrome p450, which damages DNA structures and results in mutated genomic structures [19] . In Etn-treated rats, clear cell focus formation was suppressed. It is speculated that suppressed formation of fibrotic structures is due to the suppression of focus formation.
Oxidative stress caused by ROS production is rapidly induced in the liver after NDA administration. This stress induces alterations in the antioxidant system. For example, the glutathione S-transferase and aldo-keto reductase superfamilies are upregulated [21] . These machineries function to reduce oxidative stress by converting ROS to unreactive molecules. Oxidative stress can cause hepatic injuries, in which hepatic regeneration occurs as a repair process. In regenerating loci in the liver, hepatocyte proliferation is induced by growth factors. In proliferating hepatocytes, when the machinery for cell proliferation is activated, those for other events such as metabolic reactions including the antioxidant system are also activated. Etn might potentiate the action of growth factors in the regenerating loci, eventually enhancing both hepatocyte proliferation and metabolic reactions. Activation of metabolic reactions will affect the antioxidant system. An activated antioxidant system will reduce ROS levels, thus suppressing oxidative stress.
Etn can act as a cofactor to enhance the activity of hepatocyte-specific growth factors [8] . Etn is a substrate for the synthesis of PE in many types of cells. In hepatocytes, PE is utilized to synthesize PC; specifically, PE is derivatized to PC by the action of the hepatocyte-specific enzyme PE methyltransferase (PEMT) [5] . These phospholipid metabolic pathways in hepatocytes might serve as cofactors to enhance the activity of growth factors. Indeed, after partial hepatectomy, in which hepatocyte regeneration occurs, enhanced PE synthesis is observed. In the meantime, PC synthesis via the PEMT pathway is enhanced. Consequently, a significant increase in the PE ratio was detected [11] . Therefore, enhancement of PE synthesis is a necessary event for hepatocyte proliferation in regenerating livers.
Regarding the requirement of Etn for cell proliferation, cells are classified into two types, Etn-responsive and Etn-nonresponsive. In Etn-responsive cells, Etn enhances both PE synthesis and cell proliferation. In these cells, PE synthesis is a requisite for cell proliferation. Hepatocytes are apparently Etn-responsive [8] . The de novo synthesis of PE that occurs in the presence of lower levels of Etn is not sufficient to enhance hepatocyte function. Higher levels of PE synthesis are necessary to maintain the proliferative and metabolic activities of cells. In regenerating livers, Etn might enhance hepatocyte proliferation concomitantly with enhanced metabolism. Therefore, steady-state levels of Etn might not be sufficient to efficiently activate hepatocyte function in regenerating livers following hepatectomy or NDA treatment. For more efficient hepatocyte function, exogenously administered Etn might be required.
Conclusion
The results in this report suggest that Etn can protect against cellular alterations induced by the carcinogenic chemical, NDA, presumably by enhancing hepatic phospholipid synthesis. Steady-state levels of Etn might not be sufficient to efficiently activate hepatocyte function in regenerating livers following NDA treat- 
